Annual CAPEX
$54.22 M
+$34.37 M+173.18%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual capital expenditures is currently $54.22 million, with the most recent change of +$34.37 million (+173.18%) on 31 March 2024. During the last 3 years, it has risen by +$37.07 million (+216.10%).TARO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$5.89 M
-$28.59 M-82.92%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly capital expenditures is currently $5.89 million, with the most recent change of -$28.59 million (-82.92%) on 31 March 2024. Over the past year, it has dropped by -$1.12 million (-15.93%).TARO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$54.22 M
-$2.65 M-4.66%
31 March 2024
Summary:
Taro Pharmaceutical Industries TTM capital expenditures is currently $54.22 million, with the most recent change of -$2.65 million (-4.66%) on 31 March 2024. Over the past year, it has increased by +$24.03 million (+79.61%).TARO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +173.2% | -15.9% | +79.6% |
| 3 y3 years | +216.1% | +192.9% | +285.6% |
| 5 y5 years | +76.7% | +4.3% | +74.5% |
TARO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -51.3% | -94.2% | -52.2% |
Taro Pharmaceutical Industries CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $54.22 M(+173.2%) | $5.89 M(-82.9%) | $54.22 M(-4.7%) |
| Dec 2023 | - | $34.48 M(+392.1%) | $56.87 M(+88.4%) |
| Sept 2023 | - | $7.01 M(+2.4%) | $30.19 M(+22.8%) |
| June 2023 | - | $6.84 M(-19.9%) | $24.58 M(+23.9%) |
| Mar 2023 | $19.85 M(-82.2%) | $8.54 M(+9.5%) | $19.85 M(-82.5%) |
| Dec 2022 | - | $7.80 M(+455.7%) | $113.39 M(+4.1%) |
| Sept 2022 | - | $1.40 M(-33.4%) | $108.89 M(-0.6%) |
| June 2022 | - | $2.11 M(-97.9%) | $109.50 M(-1.6%) |
| Mar 2022 | $111.32 M(+549.0%) | $102.08 M(+2990.4%) | $111.32 M(+822.6%) |
| Dec 2021 | - | $3.30 M(+64.2%) | $12.07 M(-14.2%) |
| Sept 2021 | - | $2.01 M(-48.8%) | $14.06 M(-11.5%) |
| June 2021 | - | $3.93 M(+39.0%) | $15.88 M(-7.4%) |
| Mar 2021 | $17.15 M(-39.6%) | $2.83 M(-46.7%) | $17.15 M(-23.3%) |
| Dec 2020 | - | $5.30 M(+38.2%) | $22.38 M(-6.0%) |
| Sept 2020 | - | $3.83 M(-26.2%) | $23.80 M(-7.1%) |
| June 2020 | - | $5.20 M(-35.4%) | $25.61 M(-9.9%) |
| Mar 2020 | $28.41 M(-7.4%) | $8.05 M(+19.8%) | $28.41 M(-1.5%) |
| Dec 2019 | - | $6.72 M(+18.9%) | $28.86 M(-7.1%) |
| Sept 2019 | - | $5.65 M(-29.4%) | $31.08 M(-4.6%) |
| June 2019 | - | $8.00 M(-5.8%) | $32.56 M(+6.1%) |
| Mar 2019 | $30.68 M(+3.9%) | $8.49 M(-5.0%) | $30.68 M(-5.2%) |
| Dec 2018 | - | $8.94 M(+25.4%) | $32.38 M(+10.0%) |
| Sept 2018 | - | $7.13 M(+16.5%) | $29.43 M(+1.3%) |
| June 2018 | - | $6.12 M(-39.9%) | $29.05 M(-1.7%) |
| Mar 2018 | $29.54 M(-17.6%) | $10.19 M(+70.1%) | $29.54 M(+2.6%) |
| Dec 2017 | - | $5.99 M(-11.3%) | $28.80 M(-3.8%) |
| Sept 2017 | - | $6.75 M(+2.1%) | $29.93 M(-10.0%) |
| June 2017 | - | $6.61 M(-30.0%) | $33.24 M(-7.2%) |
| Mar 2017 | $35.82 M(+87.5%) | $9.45 M(+32.7%) | $35.82 M(+11.1%) |
| Dec 2016 | - | $7.12 M(-29.3%) | $32.24 M(+2.3%) |
| Sept 2016 | - | $10.06 M(+9.5%) | $31.51 M(+21.7%) |
| June 2016 | - | $9.20 M(+56.9%) | $25.89 M(+35.5%) |
| Mar 2016 | $19.11 M(-5.2%) | $5.86 M(-8.3%) | $19.11 M(-1.4%) |
| Dec 2015 | - | $6.39 M(+43.8%) | $19.38 M(+17.5%) |
| Sept 2015 | - | $4.45 M(+84.6%) | $16.49 M(-0.6%) |
| June 2015 | - | $2.41 M(-60.8%) | $16.58 M(-17.7%) |
| Mar 2015 | $20.16 M | $6.14 M(+75.4%) | $20.16 M(+7.3%) |
| Dec 2014 | - | $3.50 M(-22.9%) | $18.78 M(-36.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $4.54 M(-24.1%) | $29.58 M(+6.1%) |
| June 2014 | - | $5.98 M(+25.7%) | $27.89 M(+8.1%) |
| Mar 2014 | $25.80 M(+151.9%) | $4.76 M(-66.7%) | $25.80 M(+6.0%) |
| Dec 2013 | - | $14.30 M(+401.9%) | $24.34 M(+77.0%) |
| Sept 2013 | - | $2.85 M(-26.9%) | $13.75 M(+11.5%) |
| June 2013 | - | $3.90 M(+18.3%) | $12.34 M(+20.5%) |
| Mar 2013 | $10.24 M(+536.2%) | $3.29 M(-11.2%) | $10.24 M(+47.4%) |
| Dec 2012 | - | $3.71 M(+158.8%) | $6.95 M(+19.1%) |
| Sept 2012 | - | $1.43 M(-20.5%) | $5.83 M(-0.4%) |
| June 2012 | - | $1.80 M(-30.5%) | $5.86 M(-6.9%) |
| Mar 2012 | $1.61 M(-74.4%) | - | - |
| Dec 2011 | $6.29 M(-41.5%) | $2.60 M(+78.0%) | $6.29 M(-0.1%) |
| Sept 2011 | - | $1.46 M(+7.8%) | $6.30 M(-34.7%) |
| June 2011 | - | $1.35 M(+52.5%) | $9.65 M(-11.2%) |
| Mar 2011 | - | $887.00 K(-65.9%) | $10.86 M(+1.0%) |
| Dec 2010 | $10.75 M(+109.0%) | $2.60 M(-45.8%) | $10.75 M(+31.9%) |
| Sept 2010 | - | $4.81 M(+87.4%) | $8.15 M(+143.7%) |
| June 2010 | - | $2.56 M(+229.3%) | $3.34 M(+329.3%) |
| Mar 2010 | - | $779.00 K | $779.00 K |
| Dec 2009 | $5.14 M(+23.5%) | - | - |
| Dec 2008 | $4.17 M(-32.9%) | - | - |
| Dec 2007 | $6.21 M(-72.0%) | - | - |
| Dec 2006 | $22.21 M(-55.4%) | - | - |
| Dec 2005 | $49.80 M(-31.1%) | - | - |
| Dec 2004 | $72.27 M(-23.5%) | - | - |
| Dec 2003 | $94.42 M(+118.3%) | - | - |
| Dec 2002 | $43.25 M(+124.6%) | - | - |
| Dec 2001 | $19.26 M(+59.0%) | - | - |
| Dec 2000 | $12.11 M(+45.9%) | - | - |
| Dec 1999 | $8.30 M(+36.1%) | - | - |
| Dec 1998 | $6.10 M(-33.0%) | - | - |
| Dec 1997 | $9.10 M(+4.6%) | - | - |
| Dec 1996 | $8.70 M(+81.3%) | - | - |
| Dec 1995 | $4.80 M(+37.1%) | - | - |
| Dec 1994 | $3.50 M(+29.6%) | - | - |
| Dec 1993 | $2.70 M(-58.5%) | - | - |
| Dec 1992 | $6.50 M(+242.1%) | - | - |
| Dec 1991 | $1.90 M | - | - |
FAQ
- What is Taro Pharmaceutical Industries annual capital expenditures?
- What is the all time high annual CAPEX for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual CAPEX year-on-year change?
- What is Taro Pharmaceutical Industries quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly CAPEX year-on-year change?
- What is Taro Pharmaceutical Industries TTM capital expenditures?
- What is the all time high TTM CAPEX for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM CAPEX year-on-year change?
What is Taro Pharmaceutical Industries annual capital expenditures?
The current annual CAPEX of TARO is $54.22 M
What is the all time high annual CAPEX for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual capital expenditures is $111.32 M
What is Taro Pharmaceutical Industries annual CAPEX year-on-year change?
Over the past year, TARO annual capital expenditures has changed by +$34.37 M (+173.18%)
What is Taro Pharmaceutical Industries quarterly capital expenditures?
The current quarterly CAPEX of TARO is $5.89 M
What is the all time high quarterly CAPEX for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly capital expenditures is $102.08 M
What is Taro Pharmaceutical Industries quarterly CAPEX year-on-year change?
Over the past year, TARO quarterly capital expenditures has changed by -$1.12 M (-15.93%)
What is Taro Pharmaceutical Industries TTM capital expenditures?
The current TTM CAPEX of TARO is $54.22 M
What is the all time high TTM CAPEX for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM capital expenditures is $113.39 M
What is Taro Pharmaceutical Industries TTM CAPEX year-on-year change?
Over the past year, TARO TTM capital expenditures has changed by +$24.03 M (+79.61%)